Gould Capital LLC acquired a new stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 4,475 shares of the technology company’s stock, valued at approximately $999,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Brooklyn Investment Group raised its position in shares of Veeva Systems by 253.4% during the fourth quarter. Brooklyn Investment Group now owns 2,792 shares of the technology company’s stock worth $628,000 after acquiring an additional 2,002 shares during the last quarter. Orion Porfolio Solutions LLC raised its position in shares of Veeva Systems by 10.4% during the fourth quarter. Orion Porfolio Solutions LLC now owns 9,701 shares of the technology company’s stock worth $2,166,000 after acquiring an additional 915 shares during the last quarter. Cibc World Markets Corp bought a new stake in shares of Veeva Systems during the fourth quarter worth $1,206,000. Pembroke Management LTD raised its position in shares of Veeva Systems by 13.3% during the fourth quarter. Pembroke Management LTD now owns 2,565 shares of the technology company’s stock worth $573,000 after acquiring an additional 302 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Veeva Systems by 10.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 516,540 shares of the technology company’s stock worth $115,313,000 after acquiring an additional 49,287 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Veeva Systems Trading Down 1.3%
NYSE:VEEV opened at $159.44 on Friday. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $310.50. The stock has a market cap of $25.90 billion, a price-to-earnings ratio of 28.42, a PEG ratio of 0.69 and a beta of 0.95. The stock has a 50-day moving average price of $165.06 and a two-hundred day moving average price of $192.11.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the company. TD Cowen restated a “buy” rating on shares of Veeva Systems in a research report on Thursday, June 4th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $275.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. Wells Fargo & Company lifted their price objective on Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a research note on Thursday, June 4th. Wall Street Zen raised Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Piper Sandler decreased their price objective on Veeva Systems from $285.00 to $235.00 and set an “overweight” rating for the company in a research note on Thursday, June 4th. Eighteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $250.96.
Get Our Latest Report on Veeva Systems
Insider Buying and Selling at Veeva Systems
In other news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director directly owned 3,253 shares of the company’s stock, valued at $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
